OR WAIT null SECS
November 06, 2018
The company has rolled out the first batch of TRACON Pharmaceutical’s lead product candidate from its Singapore-based single-use bioreactor.
November 02, 2018
A matrix of multi-functional cleanrooms can be adapted for launching products.
This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells.
November 01, 2018
New data highlights ability of the SQZ cell therapy platform to preserve cellular functions.
October 31, 2018
A project funded by BioProNET will investigate optimization for bioprocessing of gene therapy vectors using hydrodynamic fluid flow fields.
A statement from FDA Commissioner Scott Gottlieb and Deputy Commissioner Anna Abram detailed FDA’s new plan to advance plant and animal biotechnology innovation.
October 30, 2018
The acquisition will allow Lonza to further develop technology for scalable autologous cell-therapy manufacturing.
October 15, 2018
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
October 11, 2018
The new facility will include comprehensive mammalian process development and manufacturing capabilities.
October 10, 2018
The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.